Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 12
Submit an article Journal homepage
416
Views
17
CrossRef citations to date
0
Altmetric
Original Articles: Research

Analysis of class I and II histone deacetylase gene expression in human leukemia

Hui YangDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Sirisha MaddipotiDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Andres QuesadaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Zachary BohannanDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Monica Cabrero CalvoDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Simona CollaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Yue WeiDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Marcos EstecioDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA;Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
William WierdaDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Carlos Bueso-RamosDepartment of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
&
Guillermo Garcia-ManeroDepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
 show all
Pages 3426-3433 | Received 27 Oct 2014, Accepted 23 Mar 2015, Published online: 26 May 2015

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Niloufer P. Dumasia, Aparna P. Khanna & Prasad S. Pethe. (2023) Retinoic acid signaling is critical for generation of pancreatic progenitors from human embryonic stem cells. Growth Factors 41:1, pages 8-19.
Read now

Articles from other publishers (16)

Yun Deng, Qian Cheng & Jing He. (2023) HDAC inhibitors: Promising agents for leukemia treatment. Biochemical and Biophysical Research Communications 680, pages 61-72.
Crossref
Laura Urwanisch, Michael Stefan Unger, Helene Sieberer, Hieu-Hoa Dang, Theresa Neuper, Christof Regl, Julia Vetter, Susanne Schaller, Stephan M. Winkler, Emanuela Kerschbamer, Christian X. Weichenberger, Peter W. Krenn, Michela Luciano, Lisa Pleyer, Richard Greil, Christian G. Huber, Fritz Aberger & Jutta Horejs-Hoeck. (2023) The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells. Cancers 15:4, pages 1039.
Crossref
Mengjie Zhao, Yu Duan, Jiangyun Wang, Yong Liu, Yao Zhao, Haihua Wang, Lei Zhang, Zhe-Sheng Chen, Zhenbo Hu & Liuya Wei. (2022) Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with t (8; 21) or MLL Gene Translocation and Leukemic Stem-Like Cells. Journal of Oncology 2022, pages 1-13.
Crossref
Mahdieh Mehrpouri, Atieh Pourbagheri-Sigaroodi & Davood Bashash. (2021) The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies. International Immunopharmacology 100, pages 108114.
Crossref
Divya Desai, Aparna Khanna & Prasad Pethe. (2020) Inhibition of RING1B alters lineage specificity in human embryonic stem cells. Cell Biology International 44:6, pages 1299-1311.
Crossref
Jing Ye, Jie Zha, Yuanfei Shi, Yin Li, Delin Yuan, Qinwei Chen, Fusheng Lin, Zhihong Fang, Yong Yu, Yun Dai & Bing Xu. (2019) Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair. Clinical Epigenetics 11:1.
Crossref
Mariarosaria Conte, Carmela Dell'Aversana, Giulia Sgueglia, Annamaria Carissimo & Lucia Altucci. (2019) HDAC2‐dependent miRNA signature in acute myeloid leukemia. FEBS Letters 593:18, pages 2574-2584.
Crossref
Sonja C. Buisman & Gerald de Haan. (2019) Epigenetic Changes as a Target in Aging Haematopoietic Stem Cells and Age-Related Malignancies. Cells 8:8, pages 868.
Crossref
Kamira Maharaj, John J. PowersAlex AchilleSusan DengRenee FonsecaMibel Pabon-SaldanaSteven N. QuayleSimon S. JonesAlejandro Villagra, Eduardo M. Sotomayor, Eva Sahakian & Javier Pinilla-Ibarz. (2018) Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia. Blood Advances 2:21, pages 3012-3024.
Crossref
Johanna Ungerstedt. (2018) Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors. International Journal of Molecular Sciences 19:10, pages 3091.
Crossref
Maria Cosenza & Samantha Pozzi. (2018) The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease. International Journal of Molecular Sciences 19:8, pages 2337.
Crossref
Marcin W. Wlodarski, Sushree S. Sahoo & Charlotte M. Niemeyer. (2018) Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematology/Oncology Clinics of North America 32:4, pages 729-743.
Crossref
Y. Lun, J.-j. Yang & Y. Wu. (2017) Complete molecular remission in relapsed and refractory acute myeloid leukaemia with MLL-AF9 treated with chidamide-based chemotherapy. Journal of Clinical Pharmacy and Therapeutics 42:6, pages 786-789.
Crossref
Emanuely Silva Chrun, Filipe Modolo & Filipe Ivan Daniel. (2017) Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis. Pathology - Research and Practice 213:11, pages 1329-1339.
Crossref
Diana Markozashvili, Vincent Ribrag & Yegor S. Vassetzky. (2015) Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies. Investigational New Drugs 33:6, pages 1280-1291.
Crossref
Mengjie Zhao, Yu Duan, Jiangyun Wang, Yong Liu, Yao Zhao, Haihua Wang, Lei Zhang, Zhe-Sheng (Jason) Chen, Zhenbo Hu & Liuya Wei. (2022) Histone Deacetylase Inhibitor I3 Induces Differentiation of Acute Myeloid Leukemia Cells with T(8;21) or MLL Gene Translocation and Leukemic Stem-Like Cells. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.